In a new study, Weizmann Institute of Science researchers reveal a bacterial immune system that thwarts the phages’ plot by attaching a small protein molecule to their tails. The components of this ...

Armata Pharmaceuticals (ARMP) announced “encouraging” topline results from its Phase 2 trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary ...

According to the new paper, researchers fear that mirror bacteria could be able to evade natural predators like phage viruses ...

Armata Pharmaceuticals ( (ARMP) ) has issued an announcement.

The application of phage therapy for multidrug-resistant infections is mainly limited to personalized therapy due to the narrow host range of individual phages. Here, Kim et al. identify groups of ...

New research from the University of Guelph will focus on determining if bacteriophages can replace antibiotics to reduce the ...

Dr. Marisa Azad treated a patient using phage therapy, which enlists viruses to fight bacterial infections. An Ottawa ...

Qeen Biotechnologies Inc., a leader in bacteriophage-based solutions, is proud to announce its role in providing ...

Some viruses only infect bacterial cells; they are known as bacteriophages, and they have real potential to defeat antibiotic ...

Winners of UTSA’s annual Innovation Awards were recently announced, in recognition of their substantial contributions to the ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

A study offers evidence that a single bacterial species -- the host of the phage -- can maintain a diverse community of competing phage species. Knowing how more than one kind of virus can survive ...